AUG 27·SEC EDGARLow
Troendle August J. sold $2.9M of MEDP
Troendle August J. (President & CEO) sold 4,673 shares of Medpace Holdings, Inc. (MEDP) at an average of $620.08 ($620.03–$620.38, $2.90M total) across 2 trades over 2026-08-25 to 2026-08-26.
StockNASDAQ · US · USDHealthcare · Diagnostics & Research
$MEDP
Medpace Holdings, Inc.
Price · $MEDPvia TradingView
AI sentiment · 7d2 articles
- Bullish
- 0
- Neutral
- 2
- Bearish
- 0
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $71.0M 15 txs
Troendle August J.10× · $60.2M
10b5-1 share of filings0%
Top stories · $MEDPMore →
AUG 26·yahoo.com
What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock
Medpace CEO Troendle sold $10 million in stock, retaining 2.7 million shares. MEDP stock rose 32% in the past year, with Q4 sales and EPS up 17% and 37% respectively. The company's valuation is at 25 times free cash flow, above its 10-year average. Medpace's model may benefit from AI technology.
AUG 25·tradingview.com
Medpace President & CEO Sold Shares Worth Over $9.9M
Medpace's President & CEO August J. Troendle sold shares worth $9.97M at weighted average prices of $624.45 and $620.23 on August 21 and 24, respectively. Troendle now directly owns 545,217 shares and indirectly owns 4,733,019 shares via Medpace Investors, LLC, according to an SEC Form 4 filing.
MEDP sentiment & insider activity
Over the past 7 days, alphai's AI scored 2 news stories mentioning MEDP (Medpace Holdings, Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent MEDP coverage spans insider activity and financial news.
In the last 30 days, MEDP insiders filed 15 SEC Form 4 transactions — no purchases and 15 sales ($71.0M). The most active reporter was Troendle August J., President & CEO, with 10 filings.
What's driving MEDP
Insider sale may signal reduced confidence, potentially pressuring the stock short-term.
The insider sale may create short‑term selling pressure but the CEO still holds a large stake.
Medpace's President & CEO August J. Troendle sold shares worth $9.97M at weighted average prices of $624.45 and $620.23 on August 21 and 24, respectively. Troendle now directly owns 545,217 shares and indirectly owns 4,733,019 shares via Medpace Investors, LLC, according to an SEC Form 4 filing.
Large insider sale may signal reduced confidence, potentially pressuring the stock.
The sale may indicate insider confidence level but size is modest; limited immediate price impact.
alphai scores every news story that mentions MEDP with an AI model for sentiment and relevance, and aggregates insider trades from Medpace Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $MEDP
Score
Troendle August J. sold $2.9M of MEDP
Troendle August J. (President & CEO) sold 4,673 shares of Medpace Holdings, Inc. (MEDP) at an average of $620.08 ($620.03–$620.38, $2.90M total) across 2 trades over 2026-08-25 to 2026-08-26.
1 min read
What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock
Medpace CEO Troendle sold $10 million in stock, retaining 2.7 million shares. MEDP stock rose 32% in the past year, with Q4 sales and EPS up 17% and 37% respectively. The company's valuation is at 25 times free cash flow, above its 10-year average. Medpace's model may benefit from AI technology.
2 min read
Medpace President & CEO Sold Shares Worth Over $9.9M
Medpace's President & CEO August J. Troendle sold shares worth $9.97M at weighted average prices of $624.45 and $620.23 on August 21 and 24, respectively. Troendle now directly owns 545,217 shares and indirectly owns 4,733,019 shares via Medpace Investors, LLC, according to an SEC Form 4 filing.
1 min readTroendle August J. sold $10.0M of MEDP
Troendle August J. (President & CEO) sold 15,978 shares of Medpace Holdings, Inc. (MEDP) at an average of $623.93 ($620.23–$624.45, $9.97M total) across 2 trades over 2026-08-21 to 2026-08-24.
1 min readTop Medpace Executive Makes Bold Insider Move in High-Value Stock Sale - TipRanks.com
Medpace Holdings (MEDP) CFO Kevin M. Brady sold 3,400 shares for $2.13M. Recent clinical-trial updates boosted investor sentiment. Analyst Spark rates MEDP as Outperform, citing strong financials and guidance, but notes high valuation. MEDP's YTD performance is +10.52% with a $17.33B market cap.
1 min readBrady Kevin M. sold $2.1M of MEDP
Brady Kevin M. (CFO & Treasurer) sold 3,400 shares of Medpace Holdings, Inc. (MEDP) at $625.24 ($2.13M total) on 2026-08-20.
1 min readDon't Ignore The Insider Selling In Medpace Holdings
Medpace Holdings CEO August Troendle sold shares worth $26m at $614 each, reducing his holding by 0.8%. Earlier this year, he sold $62m worth at $616 per share. Insiders own 20% of the company, valued at $3.4b. No insider purchases were recorded in the last year.
2 min readTroendle August J. sold $26.3M of MEDP
Troendle August J. (President & CEO) sold 42,783 shares of Medpace Holdings, Inc. (MEDP) at an average of $614.30 ($606.47–$618.79, $26.28M total) across 2 trades over 2026-08-19 to 2026-08-20.
1 min readCarley Brian T sold $3.0M of MEDP
Carley Brian T sold 5,000 shares of Medpace Holdings, Inc. (MEDP) at $608.63 ($3.04M total) on 2026-08-19.
1 min readDAVENPORT FRED B JR sold $4.4M of MEDP
DAVENPORT FRED B JR sold 7,283 shares of Medpace Holdings, Inc. (MEDP) at $606.15 ($4.41M total) on 2026-08-19.
1 min read